Niacinamide Market By Type (Powder, Liquid, Others), By Application (Pharmaceutical, Cosmeceutical, Human Nutrition), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Drug stores and Retail Pharmacies): Global Opportunity Analysis and Industry Forecast, 2021-2031

Niacinamide Market

Niacinamide is the form of vitamin B3, which has a large number of applications in pharmaceuticals, nutraceuticals, and cosmeceuticals. Vitamin B3 deficiency can be avoided by administering niacinamide in various dosage forms including powders, liquids, injection, tablets, and capsules.

According to National Center for Biotechnology Information (NCBI), individual skin diseases varied in size from 0.38% for dermatitis (atopic, contact, and seborrhea dermatitis), 0.29% for acne vulgaris, 0.19% for psoriasis, 0.15% for fungal skin diseases, 0.06% for malignant skin melanoma, 0.03% for keratinocyte carcinoma, and remaining percentage of other disease. The rising number of this skin related diseases gave rise to various treatments options including the niacinamide products that are used to treat many of the above conditions, thus causing the rise in the sales of the niacinamide products.

As vitamin B3 helps the immune system by reducing inflammation and damage to the lungs, there was a great demand for products that boost immunity during the COVID-19 pandemic. In addition, the growth of the niacinamide market trends is attributed to growth in demand for nutritionally enriched processed products and prevalence of vitamin B3 deficiencies.

In addition, The COVID-19 pandemic has proved to be an incomparable global public health emergency that has affected almost every industry, and the effects are expected to impact every industry growth during the forecast period. Several changes in consumer demand and behavior, buying habits, supply chain redirection, and significant government initiatives have been seen around the globe. The COVID-19 pandemic has changed nutrition pattern, other substance use, and health-related behaviors of the population. In addition, people have adopted healthy nutritional supplements to increase their immunity during the pandemic. Such factors, in turn, propel the growth of niacinamide market size.

According to the type, based on niacinamide market analysis, liquid was the largest segment in 2021, and is expected to grow at a highest CAGR of 5.0% during the niacinamide market forecast period, owing to increase in usage of niacinamide solutions that are used in skin treatments, rising concerns about skin care, and large number of product offering by market players.

By application, the cosmeceutical segment held a dominant portion in the global niacinamide market in 2021. The segment is expected to grow at the fastest rate with a CAGR of 4.8% during the forecast period.

By distribution channel, the drug stores & retail pharmacies segment owned the largest niacinamide market share in 2021. On the other hand, the online pharmacies segment is expected to grow at the highest CAGR during the forecast period, owing to easy accessibility, time saving, and heavy discounts & offers provided by these online platforms, which also boosts sales of niacinamide containing medications.

Region wise, in niacinamide industry, North America acquired a major share, owing to presence of key players, rise in government initiatives, well-developed healthcare infrastructure, and rise in prevalence of health issues. However, Asia-Pacific is expected to witness highest growth rate with a CAGR of 6.1% for the niacinamide market throughout the forecast period.

Major companies profiled in this niacinamide industry include Brother Enterprises Holding Co., Ltd, Evonik Industries AG, Fagron Inc, Foodchem International Corporation, Glossier, Jubilant Life Sciences Limited, Koninklijke DSM N.V, Lasons India Pvt Ltd, Lonza Group, Merck KGAA, and Veer Chemie, Vertellus.

Key findings of the study

By type, the liquid segment was the highest contributor to the market in 2021.

By application, the cosmeceutical segment was the highest contributor to the market in 2021, and is expected to continue this trend during the forecast period.

Depending on distribution channel, the drug stores & retail pharmacies segment was highest contributor in 2021.

Region wise, North America garnered largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Overview

The global niacinamide market was valued at $546.08 million in 2021, and is projected to reach $832.41 million by 2031, registering a CAGR of 4.3% from 2022 to 2031.

Niacinamide, a form of vitamin B3, is an essential nutrient in human body. Vitamin B3 deficiency can lead to skin disorders, kidney, and brain diseases, which can be treated by administering niacinamide products and supplements. Niacinamide can be obtained both naturally and synthetically. Naturally it is obtained from both beef and chicken livers and from eggs, fish, meat, and green vegetables. Synthetically it is produced by hydrolysis of nicotinonitrile, which is catalyzed by the enzyme nitrile hydratase from Rhodococcus rhodochrous.

World Health Organization (WHO) states that skin diseases are among the most common of all human health conditions and affects almost 900 million people in the world at any time. This skin conditions can be well treated by using niacinamide which includes reducing redness from eczema, acne, and other inflammatory skin conditions. In addition, it is used to prevent dermatological conditions, including autoimmune blistering disorders, acne, rosacea, ageing skin, and atopic dermatitis. Hence, owing to these applications, there is a greater demand for the drug in the cosmeceuticals sector, which propels growth of the market. Niacin has long been used to lower triglycerides and increase high-density lipoprotein (HDL) cholesterol. This further highlights its demand in the pharmaceuticals segment causing increase in sales of products.

In addition, vitamin B3 enhances digestive health in dairy cattle, which prevents metabolic diseases. According to the U.S. department of agriculture, supplementation of 12g of niacin per head per day can increase milk production by about 1lb. This further propels increase in demand for niacinamide for animals to enhance their digestive health. For instance, Niacin RP is the niacinamide nutrition developed by Jubilant Ingrevia, which is expected to propel the market growth.

Increase in awareness regarding benefits of niacinamide, rise in usage of cosmetic products, and rise and investments in research & development activities are the key drivers that lead to growth of the market. Top market players are investing in research and development activities to develop new niacinamide containing products. In addition, product launch and building a strong product portfolio is the major focus of the players. In addition, increasing consumer awareness and concerns about health benefits provides opportunities to the market players to manufacture products which have proven to be highly effective. Along with this, the growing prevalence of the skin related diseases, increasing vitamin B3 deficiency cases around the globe and increasing awareness among the people regarding the consumption of healthy food supplements provides a favorable environment for increasing sales of niacinamide products and for growth of the overall market. Furthermore, side effects associated with long-term use of niacinamide can affect sales of the products and hinder growth of the market.

The niacinamide market is segmented on the basis of type, application, distribution channel, and region. By type, it is divided into powder, liquid, and others. Further, the powder segment is divided into natural and synthetic. On the basis of application, the market is segmented into pharmaceutical, cosmeceutical, and human nutrition. According to the distribution channel, it is segmented into hospital pharmacies, online pharmacies, and drug stores & retail pharmacies. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Major companies profiled in this report include Brother Enterprises Holding Co., Ltd, Evonik Industries AG, Fagron Inc, Foodchem International Corporation, Glossier, Jubilant Life Sciences Limited, Koninklijke DSM N.V, Lasons India Pvt Ltd, Lonza Group, Merck KGAA, and Veer Chemie, Vertellus.

Key Benefits For Stakeholders

●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the niacinamide market analysis from 2021 to 2031 to identify the prevailing niacinamide market opportunities.

●The market research is offered along with information related to key drivers, restraints, and opportunities.

●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

●In-depth analysis of the niacinamide market segmentation assists to determine the prevailing market opportunities.

●Major countries in each region are mapped according to their revenue contribution to the global market.

●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

●The report includes the analysis of the regional as well as global niacinamide market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

○ Vertellu

Scope of Niacinamide Market Report

1.1.Report description

1.2.Key market segments

1.3.Key benefits to the stakeholders

1.4.Research Methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

2.1.Key findings of the study

2.2.CXO Perspective

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis

3.4.Top player positioning

3.5.Market dynamics

3.5.1.Drivers

3.5.2.Restraints

3.5.3.Opportunities

3.6.COVID-19 Impact Analysis on the market

3.7.Patent Landscape

4.1 Overview

4.1.1 Market size and forecast

4.2 Powder

4.2.1 Key market trends, growth factors and opportunities

4.2.2 Market size and forecast, by region

4.2.3 Market analysis by country

4.2.4 Powder Niacinamide Market by Type

4.2.4.1 Natural Market size and forecast, by region

4.2.4.2 Synthetic Market size and forecast, by region

4.3 Liquid

4.3.1 Key market trends, growth factors and opportunities

4.3.2 Market size and forecast, by region

4.3.3 Market analysis by country

4.4 Others

4.4.1 Key market trends, growth factors and opportunities

4.4.2 Market size and forecast, by region

4.4.3 Market analysis by country

5.1 Overview

5.1.1 Market size and forecast

5.2 Pharmaceutical

5.2.1 Key market trends, growth factors and opportunities

5.2.2 Market size and forecast, by region

5.2.3 Market analysis by country

5.3 Cosmeceutical

5.3.1 Key market trends, growth factors and opportunities

5.3.2 Market size and forecast, by region

5.3.3 Market analysis by country

5.4 Human Nutrition

5.4.1 Key market trends, growth factors and opportunities

5.4.2 Market size and forecast, by region

5.4.3 Market analysis by country

6.1 Overview

6.1.1 Market size and forecast

6.2 Hospital Pharmacies

6.2.1 Key market trends, growth factors and opportunities

6.2.2 Market size and forecast, by region

6.2.3 Market analysis by country

6.3 Online Pharmacies

6.3.1 Key market trends, growth factors and opportunities

6.3.2 Market size and forecast, by region

6.3.3 Market analysis by country

6.4 Drug stores and Retail Pharmacies

6.4.1 Key market trends, growth factors and opportunities

6.4.2 Market size and forecast, by region

6.4.3 Market analysis by country

7.1 Overview

7.1.1 Market size and forecast

7.2 North America

7.2.1 Key trends and opportunities

7.2.2 North America Market size and forecast, by Type

7.2.2.1 North America Powder Niacinamide Market by Type

7.2.3 North America Market size and forecast, by Application

7.2.4 North America Market size and forecast, by Distribution Channel

7.2.5 North America Market size and forecast, by country

7.2.5.1 U.S.

7.2.5.1.1 Market size and forecast, by Type

7.2.5.1.2 Market size and forecast, by Application

7.2.5.1.3 Market size and forecast, by Distribution Channel

7.2.5.2 Canada

7.2.5.2.1 Market size and forecast, by Type

7.2.5.2.2 Market size and forecast, by Application

7.2.5.2.3 Market size and forecast, by Distribution Channel

7.2.5.3 Mexico

7.2.5.3.1 Market size and forecast, by Type

7.2.5.3.2 Market size and forecast, by Application

7.2.5.3.3 Market size and forecast, by Distribution Channel

7.3 Europe

7.3.1 Key trends and opportunities

7.3.2 Europe Market size and forecast, by Type

7.3.2.1 Europe Powder Niacinamide Market by Type

7.3.3 Europe Market size and forecast, by Application

7.3.4 Europe Market size and forecast, by Distribution Channel

7.3.5 Europe Market size and forecast, by country

7.3.5.1 Germany

7.3.5.1.1 Market size and forecast, by Type

7.3.5.1.2 Market size and forecast, by Application

7.3.5.1.3 Market size and forecast, by Distribution Channel

7.3.5.2 France

7.3.5.2.1 Market size and forecast, by Type

7.3.5.2.2 Market size and forecast, by Application

7.3.5.2.3 Market size and forecast, by Distribution Channel

7.3.5.3 UK

7.3.5.3.1 Market size and forecast, by Type

7.3.5.3.2 Market size and forecast, by Application

7.3.5.3.3 Market size and forecast, by Distribution Channel

7.3.5.4 Italy

7.3.5.4.1 Market size and forecast, by Type

7.3.5.4.2 Market size and forecast, by Application

7.3.5.4.3 Market size and forecast, by Distribution Channel

7.3.5.5 Spain

7.3.5.5.1 Market size and forecast, by Type

7.3.5.5.2 Market size and forecast, by Application

7.3.5.5.3 Market size and forecast, by Distribution Channel

7.3.5.6 Rest of Europe

7.3.5.6.1 Market size and forecast, by Type

7.3.5.6.2 Market size and forecast, by Application

7.3.5.6.3 Market size and forecast, by Distribution Channel

7.4 Asia-Pacific

7.4.1 Key trends and opportunities

7.4.2 Asia-Pacific Market size and forecast, by Type

7.4.2.1 Asia-Pacific Powder Niacinamide Market by Type

7.4.3 Asia-Pacific Market size and forecast, by Application

7.4.4 Asia-Pacific Market size and forecast, by Distribution Channel

7.4.5 Asia-Pacific Market size and forecast, by country

7.4.5.1 Japan

7.4.5.1.1 Market size and forecast, by Type

7.4.5.1.2 Market size and forecast, by Application

7.4.5.1.3 Market size and forecast, by Distribution Channel

7.4.5.2 China

7.4.5.2.1 Market size and forecast, by Type

7.4.5.2.2 Market size and forecast, by Application

7.4.5.2.3 Market size and forecast, by Distribution Channel

7.4.5.3 Australia

7.4.5.3.1 Market size and forecast, by Type

7.4.5.3.2 Market size and forecast, by Application

7.4.5.3.3 Market size and forecast, by Distribution Channel

7.4.5.4 India

7.4.5.4.1 Market size and forecast, by Type

7.4.5.4.2 Market size and forecast, by Application

7.4.5.4.3 Market size and forecast, by Distribution Channel

7.4.5.5 South Korea

7.4.5.5.1 Market size and forecast, by Type

7.4.5.5.2 Market size and forecast, by Application

7.4.5.5.3 Market size and forecast, by Distribution Channel

7.4.5.6 Rest of Asia-Pacific

7.4.5.6.1 Market size and forecast, by Type

7.4.5.6.2 Market size and forecast, by Application

7.4.5.6.3 Market size and forecast, by Distribution Channel

7.5 LAMEA

7.5.1 Key trends and opportunities

7.5.2 LAMEA Market size and forecast, by Type

7.5.2.1 LAMEA Powder Niacinamide Market by Type

7.5.3 LAMEA Market size and forecast, by Application

7.5.4 LAMEA Market size and forecast, by Distribution Channel

7.5.5 LAMEA Market size and forecast, by country

7.5.5.1 Brazil

7.5.5.1.1 Market size and forecast, by Type

7.5.5.1.2 Market size and forecast, by Application

7.5.5.1.3 Market size and forecast, by Distribution Channel

7.5.5.2 Saudi Arabia

7.5.5.2.1 Market size and forecast, by Type

7.5.5.2.2 Market size and forecast, by Application

7.5.5.2.3 Market size and forecast, by Distribution Channel

7.5.5.3 South Africa

7.5.5.3.1 Market size and forecast, by Type

7.5.5.3.2 Market size and forecast, by Application

7.5.5.3.3 Market size and forecast, by Distribution Channel

7.5.5.4 Rest of LAMEA

7.5.5.4.1 Market size and forecast, by Type

7.5.5.4.2 Market size and forecast, by Application

7.5.5.4.3 Market size and forecast, by Distribution Channel

8.1. Introduction

8.2. Top winning strategies

8.3. Product Mapping of Top 10 Player

8.4. Competitive Dashboard

8.5. Competitive Heatmap

8.6. Key developments

9.1 Brother Enterprises Holding Co., Ltd

9.1.1 Company overview

9.1.2 Company snapshot

9.1.3 Operating business segments

9.1.4 Product portfolio

9.1.5 Business performance

9.1.6 Key strategic moves and developments

9.2 Evonik Industries AG

9.2.1 Company overview

9.2.2 Company snapshot

9.2.3 Operating business segments

9.2.4 Product portfolio

9.2.5 Business performance

9.2.6 Key strategic moves and developments

9.3 Fagron Inc.

9.3.1 Company overview

9.3.2 Company snapshot

9.3.3 Operating business segments

9.3.4 Product portfolio

9.3.5 Business performance

9.3.6 Key strategic moves and developments

9.4 Foodchem International

9.4.1 Company overview

9.4.2 Company snapshot

9.4.3 Operating business segments

9.4.4 Product portfolio

9.4.5 Business performance

9.4.6 Key strategic moves and developments

9.5 Glossier

9.5.1 Company overview

9.5.2 Company snapshot

9.5.3 Operating business segments

9.5.4 Product portfolio

9.5.5 Business performance

9.5.6 Key strategic moves and developments

9.6 Jubilant Life Sciences Limited

9.6.1 Company overview

9.6.2 Company snapshot

9.6.3 Operating business segments

9.6.4 Product portfolio

9.6.5 Business performance

9.6.6 Key strategic moves and developments

9.7 Koninklijke DSM N.V

9.7.1 Company overview

9.7.2 Company snapshot

9.7.3 Operating business segments

9.7.4 Product portfolio

9.7.5 Business performance

9.7.6 Key strategic moves and developments

9.8 Lasons India Pvt Ltd

9.8.1 Company overview

9.8.2 Company snapshot

9.8.3 Operating business segments

9.8.4 Product portfolio

9.8.5 Business performance

9.8.6 Key strategic moves and developments

9.9 Lonza Group

9.9.1 Company overview

9.9.2 Company snapshot

9.9.3 Operating business segments

9.9.4 Product portfolio

9.9.5 Business performance

9.9.6 Key strategic moves and developments

9.10 Merck KGAA

9.10.1 Company overview

9.10.2 Company snapshot

9.10.3 Operating business segments

9.10.4 Product portfolio

9.10.5 Business performance

9.10.6 Key strategic moves and developments

9.11 Veer Chemie

9.11.1 Company overview

9.11.2 Company snapshot

9.11.3 Operating business segments

9.11.4 Product portfolio

9.11.5 Business performance

9.11.6 Key strategic moves and developments

9.12 Vertellus

9.12.1 Company overview

9.12.2 Company snapshot

9.12.3 Operating business segments

9.12.4 Product portfolio

9.12.5 Business performance

9.12.6 Key strategic moves and development

LIST OF TABLES

TABLE 1. GLOBAL NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 2. NIACINAMIDE MARKET, FOR POWDER, BY REGION, 2021-2031 ($MILLION)

TABLE 3. NIACINAMIDE MARKET FOR POWDER, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 4. GLOBAL POWDER NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 5. NIACINAMIDE MARKET, FOR NATURAL, BY REGION, 2021-2031 ($MILLION)

TABLE 6. NIACINAMIDE MARKET, FOR SYNTHETIC, BY REGION, 2021-2031 ($MILLION)

TABLE 7. NIACINAMIDE MARKET, FOR LIQUID, BY REGION, 2021-2031 ($MILLION)

TABLE 8. NIACINAMIDE MARKET FOR LIQUID, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 9. NIACINAMIDE MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)

TABLE 10. NIACINAMIDE MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 11. GLOBAL NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 12. NIACINAMIDE MARKET, FOR PHARMACEUTICAL, BY REGION, 2021-2031 ($MILLION)

TABLE 13. NIACINAMIDE MARKET FOR PHARMACEUTICAL, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 14. NIACINAMIDE MARKET, FOR COSMECEUTICAL, BY REGION, 2021-2031 ($MILLION)

TABLE 15. NIACINAMIDE MARKET FOR COSMECEUTICAL, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 16. NIACINAMIDE MARKET, FOR HUMAN NUTRITION, BY REGION, 2021-2031 ($MILLION)

TABLE 17. NIACINAMIDE MARKET FOR HUMAN NUTRITION, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 18. GLOBAL NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)

TABLE 19. NIACINAMIDE MARKET, FOR HOSPITAL PHARMACIES, BY REGION, 2021-2031 ($MILLION)

TABLE 20. NIACINAMIDE MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 21. NIACINAMIDE MARKET, FOR ONLINE PHARMACIES, BY REGION, 2021-2031 ($MILLION)

TABLE 22. NIACINAMIDE MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 23. NIACINAMIDE MARKET, FOR DRUG STORES AND RETAIL PHARMACIES, BY REGION, 2021-2031 ($MILLION)

TABLE 24. NIACINAMIDE MARKET FOR DRUG STORES AND RETAIL PHARMACIES, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 25. NIACINAMIDE MARKET, BY REGION, 2021-2031 ($MILLION)

TABLE 26. NORTH AMERICA NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 27. NORTH AMERICA POWDER NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 28. NORTH AMERICA NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 29. NORTH AMERICA NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)

TABLE 30. NORTH AMERICA NIACINAMIDE MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 31. U.S. NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 32. U.S. NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 33. U.S. NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)

TABLE 34. CANADA NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 35. CANADA NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 36. CANADA NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)

TABLE 37. MEXICO NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 38. MEXICO NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 39. MEXICO NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)

TABLE 40. EUROPE NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 41. EUROPE POWDER NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 42. EUROPE NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 43. EUROPE NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)

TABLE 44. EUROPE NIACINAMIDE MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 45. GERMANY NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 46. GERMANY NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 47. GERMANY NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)

TABLE 48. FRANCE NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 49. FRANCE NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 50. FRANCE NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)

TABLE 51. UK NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 52. UK NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 53. UK NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)

TABLE 54. ITALY NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 55. ITALY NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 56. ITALY NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)

TABLE 57. SPAIN NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 58. SPAIN NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 59. SPAIN NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)

TABLE 60. REST OF EUROPE NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 61. REST OF EUROPE NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 62. REST OF EUROPE NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)

TABLE 63. ASIA-PACIFIC NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 64. ASIA-PACIFIC POWDER NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 65. ASIA-PACIFIC NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 66. ASIA-PACIFIC NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)

TABLE 67. ASIA-PACIFIC NIACINAMIDE MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 68. JAPAN NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 69. JAPAN NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 70. JAPAN NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)

TABLE 71. CHINA NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 72. CHINA NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 73. CHINA NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)

TABLE 74. AUSTRALIA NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 75. AUSTRALIA NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 76. AUSTRALIA NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)

TABLE 77. INDIA NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 78. INDIA NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 79. INDIA NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)

TABLE 80. SOUTH KOREA NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 81. SOUTH KOREA NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 82. SOUTH KOREA NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)

TABLE 83. REST OF ASIA-PACIFIC NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 84. REST OF ASIA-PACIFIC NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 85. REST OF ASIA-PACIFIC NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)

TABLE 86. LAMEA NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 87. LAMEA POWDER NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 88. LAMEA NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 89. LAMEA NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)

TABLE 90. LAMEA NIACINAMIDE MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 91. BRAZIL NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 92. BRAZIL NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 93. BRAZIL NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)

TABLE 94. SAUDI ARABIA NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 95. SAUDI ARABIA NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 96. SAUDI ARABIA NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)

TABLE 97. SOUTH AFRICA NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 98. SOUTH AFRICA NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 99. SOUTH AFRICA NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)

TABLE 100. REST OF LAMEA NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 101. REST OF LAMEA NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 102. REST OF LAMEA NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)

TABLE 103.BROTHER ENTERPRISES HOLDING CO., LTD: COMPANY SNAPSHOT

TABLE 104.BROTHER ENTERPRISES HOLDING CO., LTD: OPERATING SEGMENTS

TABLE 105.BROTHER ENTERPRISES HOLDING CO., LTD: PRODUCT PORTFOLIO

TABLE 106.BROTHER ENTERPRISES HOLDING CO., LTD: NET SALES,

TABLE 107.BROTHER ENTERPRISES HOLDING CO., LTD: KEY STRATERGIES

TABLE 108.EVONIK INDUSTRIES AG: COMPANY SNAPSHOT

TABLE 109.EVONIK INDUSTRIES AG: OPERATING SEGMENTS

TABLE 110.EVONIK INDUSTRIES AG: PRODUCT PORTFOLIO

TABLE 111.EVONIK INDUSTRIES AG: NET SALES,

TABLE 112.EVONIK INDUSTRIES AG: KEY STRATERGIES

TABLE 113.FAGRON INC.: COMPANY SNAPSHOT

TABLE 114.FAGRON INC.: OPERATING SEGMENTS

TABLE 115.FAGRON INC.: PRODUCT PORTFOLIO

TABLE 116.FAGRON INC.: NET SALES,

TABLE 117.FAGRON INC.: KEY STRATERGIES

TABLE 118.FOODCHEM INTERNATIONAL: COMPANY SNAPSHOT

TABLE 119.FOODCHEM INTERNATIONAL: OPERATING SEGMENTS

TABLE 120.FOODCHEM INTERNATIONAL: PRODUCT PORTFOLIO

TABLE 121.FOODCHEM INTERNATIONAL: NET SALES,

TABLE 122.FOODCHEM INTERNATIONAL: KEY STRATERGIES

TABLE 123.GLOSSIER: COMPANY SNAPSHOT

TABLE 124.GLOSSIER: OPERATING SEGMENTS

TABLE 125.GLOSSIER: PRODUCT PORTFOLIO

TABLE 126.GLOSSIER: NET SALES,

TABLE 127.GLOSSIER: KEY STRATERGIES

TABLE 128.JUBILANT LIFE SCIENCES LIMITED: COMPANY SNAPSHOT

TABLE 129.JUBILANT LIFE SCIENCES LIMITED: OPERATING SEGMENTS

TABLE 130.JUBILANT LIFE SCIENCES LIMITED: PRODUCT PORTFOLIO

TABLE 131.JUBILANT LIFE SCIENCES LIMITED: NET SALES,

TABLE 132.JUBILANT LIFE SCIENCES LIMITED: KEY STRATERGIES

TABLE 133.KONINKLIJKE DSM N.V: COMPANY SNAPSHOT

TABLE 134.KONINKLIJKE DSM N.V: OPERATING SEGMENTS

TABLE 135.KONINKLIJKE DSM N.V: PRODUCT PORTFOLIO

TABLE 136.KONINKLIJKE DSM N.V: NET SALES,

TABLE 137.KONINKLIJKE DSM N.V: KEY STRATERGIES

TABLE 138.LASONS INDIA PVT LTD: COMPANY SNAPSHOT

TABLE 139.LASONS INDIA PVT LTD: OPERATING SEGMENTS

TABLE 140.LASONS INDIA PVT LTD: PRODUCT PORTFOLIO

TABLE 141.LASONS INDIA PVT LTD: NET SALES,

TABLE 142.LASONS INDIA PVT LTD: KEY STRATERGIES

TABLE 143.LONZA GROUP: COMPANY SNAPSHOT

TABLE 144.LONZA GROUP: OPERATING SEGMENTS

TABLE 145.LONZA GROUP: PRODUCT PORTFOLIO

TABLE 146.LONZA GROUP: NET SALES,

TABLE 147.LONZA GROUP: KEY STRATERGIES

TABLE 148.MERCK KGAA: COMPANY SNAPSHOT

TABLE 149.MERCK KGAA: OPERATING SEGMENTS

TABLE 150.MERCK KGAA: PRODUCT PORTFOLIO

TABLE 151.MERCK KGAA: NET SALES,

TABLE 152.MERCK KGAA: KEY STRATERGIES

TABLE 153.VEER CHEMIE: COMPANY SNAPSHOT

TABLE 154.VEER CHEMIE: OPERATING SEGMENTS

TABLE 155.VEER CHEMIE: PRODUCT PORTFOLIO

TABLE 156.VEER CHEMIE: NET SALES,

TABLE 157.VEER CHEMIE: KEY STRATERGIES

TABLE 158.VERTELLUS: COMPANY SNAPSHOT

TABLE 159.VERTELLUS: OPERATING SEGMENTS

TABLE 160.VERTELLUS: PRODUCT PORTFOLIO

TABLE 161.VERTELLUS: NET SALES,

TABLE 162.VERTELLUS: KEY STRATERGIES LIST OF FIGURES

FIGURE 1.NIACINAMIDE MARKET SEGMENTATION

FIGURE 2.NIACINAMIDE MARKET,2021-2031

FIGURE 3.NIACINAMIDE MARKET,2021-2031

FIGURE 4. TOP INVESTMENT POCKETS, BY REGION

FIGURE 5.PORTER FIVE-1

FIGURE 6.PORTER FIVE-2

FIGURE 7.PORTER FIVE-3

FIGURE 8.PORTER FIVE-4

FIGURE 9.PORTER FIVE-5

FIGURE 10.TOP PLAYER POSITIONING

FIGURE 11.NIACINAMIDE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 12.PATENT ANALYSIS BY COMPANY

FIGURE 13.PATENT ANALYSIS BY COUNTRY

FIGURE 14.NIACINAMIDE MARKET,BY TYPE,2021(%)

FIGURE 15.COMPARATIVE SHARE ANALYSIS OF POWDER NIACINAMIDE MARKET,2021-2031(%)

FIGURE 16.COMPARATIVE SHARE ANALYSIS OF LIQUID NIACINAMIDE MARKET,2021-2031(%)

FIGURE 17.COMPARATIVE SHARE ANALYSIS OF OTHERS NIACINAMIDE MARKET,2021-2031(%)

FIGURE 18.NIACINAMIDE MARKET,BY APPLICATION,2021(%)

FIGURE 19.COMPARATIVE SHARE ANALYSIS OF PHARMACEUTICAL NIACINAMIDE MARKET,2021-2031(%)

FIGURE 20.COMPARATIVE SHARE ANALYSIS OF COSMECEUTICAL NIACINAMIDE MARKET,2021-2031(%)

FIGURE 21.COMPARATIVE SHARE ANALYSIS OF HUMAN NUTRITION NIACINAMIDE MARKET,2021-2031(%)

FIGURE 22.NIACINAMIDE MARKET,BY DISTRIBUTION CHANNEL,2021(%)

FIGURE 23.COMPARATIVE SHARE ANALYSIS OF HOSPITAL PHARMACIES NIACINAMIDE MARKET,2021-2031(%)

FIGURE 24.COMPARATIVE SHARE ANALYSIS OF ONLINE PHARMACIES NIACINAMIDE MARKET,2021-2031(%)

FIGURE 25.COMPARATIVE SHARE ANALYSIS OF DRUG STORES AND RETAIL PHARMACIES NIACINAMIDE MARKET,2021-2031(%)

FIGURE 26.NIACINAMIDE MARKET BY REGION,2021

FIGURE 27.U.S. NIACINAMIDE MARKET,2021-2031($MILLION)

FIGURE 28.CANADA NIACINAMIDE MARKET,2021-2031($MILLION)

FIGURE 29.MEXICO NIACINAMIDE MARKET,2021-2031($MILLION)

FIGURE 30.GERMANY NIACINAMIDE MARKET,2021-2031($MILLION)

FIGURE 31.FRANCE NIACINAMIDE MARKET,2021-2031($MILLION)

FIGURE 32.UK NIACINAMIDE MARKET,2021-2031($MILLION)

FIGURE 33.ITALY NIACINAMIDE MARKET,2021-2031($MILLION)

FIGURE 34.SPAIN NIACINAMIDE MARKET,2021-2031($MILLION)

FIGURE 35.REST OF EUROPE NIACINAMIDE MARKET,2021-2031($MILLION)

FIGURE 36.JAPAN NIACINAMIDE MARKET,2021-2031($MILLION)

FIGURE 37.CHINA NIACINAMIDE MARKET,2021-2031($MILLION)

FIGURE 38.AUSTRALIA NIACINAMIDE MARKET,2021-2031($MILLION)

FIGURE 39.INDIA NIACINAMIDE MARKET,2021-2031($MILLION)

FIGURE 40.SOUTH KOREA NIACINAMIDE MARKET,2021-2031($MILLION)

FIGURE 41.REST OF ASIA-PACIFIC NIACINAMIDE MARKET,2021-2031($MILLION)

FIGURE 42.BRAZIL NIACINAMIDE MARKET,2021-2031($MILLION)

FIGURE 43.SAUDI ARABIA NIACINAMIDE MARKET,2021-2031($MILLION)

FIGURE 44.SOUTH AFRICA NIACINAMIDE MARKET,2021-2031($MILLION)

FIGURE 45.REST OF LAMEA NIACINAMIDE MARKET,2021-2031($MILLION)

FIGURE 46. TOP WINNING STRATEGIES, BY YEAR

FIGURE 47. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 48. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 49.PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 50.COMPETITIVE DASHBOARD

FIGURE 51.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS

FIGURE 52.BROTHER ENTERPRISES HOLDING CO., LTD.: NET SALES ,($MILLION)

FIGURE 53.EVONIK INDUSTRIES AG.: NET SALES ,($MILLION)

FIGURE 54.FAGRON INC..: NET SALES ,($MILLION)

FIGURE 55.FOODCHEM INTERNATIONAL.: NET SALES ,($MILLION)

FIGURE 56.GLOSSIER.: NET SALES ,($MILLION)

FIGURE 57.JUBILANT LIFE SCIENCES LIMITED.: NET SALES ,($MILLION)

FIGURE 58.KONINKLIJKE DSM N.V.: NET SALES ,($MILLION)

FIGURE 59.LASONS INDIA PVT LTD.: NET SALES ,($MILLION)

FIGURE 60.LONZA GROUP.: NET SALES ,($MILLION)

FIGURE 61.MERCK KGAA.: NET SALES ,($MILLION)

FIGURE 62.VEER CHEMIE.: NET SALES ,($MILLION)

FIGURE 63.VERTELLUS.: NET SALES ,($MILLION